$468 $279 for your first year. Make up your own mind. Build robust opinions with the FT’s trusted journalism. Offer available here until 24th October.
The co-founder of biotech firm Regeneron Pharmaceuticals (NASDAQ:REGN) said in a newspaper interview that popular weight-loss ...
Hypertension is a very common condition, affecting about half of all adults in the U.S. But it doesn’t always have symptoms, ...